Can We Treat Neuroinflammation in Alzheimer's Disease?

Sánchez-Sarasúa, Sandra; Fernández-Pérez, Iván; Espinosa-Fernández, Verónica; Sánchez-Pérez, Ana María; Ledesma, Juan Carlos

Sánchez-Sarasúa, Sandra; Fernández-Pérez, Iván; Espinosa-Fernández, Verónica; Sánchez-Pérez, Ana María; Ledesma, Juan Carlos.

Affiliation

Sánchez-Sarasúa S; Neurobiotechnology Group, Department of Medicine, Health Science Faculty, Universitat Jaume I, 12071 Castellón, Spain.
Fernández-Pérez I; Neurobiotechnology Group, Department of Medicine, Health Science Faculty, Universitat Jaume I, 12071 Castellón, Spain.
Espinosa-Fernández V; Neurobiotechnology Group, Department of Medicine, Health Science Faculty, Universitat Jaume I, 12071 Castellón, Spain.
Sánchez-Pérez AM; Neurobiotechnology Group, Department of Medicine, Health Science Faculty, Universitat Jaume I, 12071 Castellón, Spain.
Ledesma JC; Neurobiotechnology Group, Department of Medicine, Health Science Faculty, Universitat Jaume I, 12071 Castellón, Spain.

Int J Mol Sci ; 21(22)2020 Nov 19.

Article in En | MEDLINE | ID: mdl-33228179

Subject(s)

Aging/genetics; Alzheimer Disease/drug therapy; Anti-Inflammatory Agents/therapeutic use; Cannabinoids/therapeutic use; Hypoglycemic Agents/therapeutic use; Neuroprotective Agents/therapeutic use; Aging/pathology; Alzheimer Disease/genetics; Alzheimer Disease/immunology; Alzheimer Disease/physiopathology; Clinical Trials as Topic; Cognitive Dysfunction/genetics; Cognitive Dysfunction/immunology; Cognitive Dysfunction/physiopathology; Cognitive Dysfunction/prevention & control; Depression/genetics; Depression/immunology; Depression/physiopathology; Depression/prevention & control; Dietary Supplements; Gastrointestinal Microbiome/immunology; Humans; Inflammation; Insulin Resistance; Metabolic Syndrome/genetics; Metabolic Syndrome/immunology; Metabolic Syndrome/physiopathology; Metabolic Syndrome/prevention & control; Neuroimmunomodulation/drug effects; Stress, Psychological/genetics; Stress, Psychological/immunology; Stress, Psychological/physiopathology; Stress, Psychological/prevention & control

Key words

Alzheimer's disease; endocannabinoid system; gut microbiota; insulin resistance; neuroinflammation; nutraceuticals

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Aging / Cannabinoids / Neuroprotective Agents / Alzheimer Disease / Hypoglycemic Agents / Anti-Inflammatory Agents Type of study: Prognostic_studies / Risk_factors_studies / Systematic_reviews Language: En Journal: Int J Mol Sci Year: 2020 Type: Article Affiliation country: Spain

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google